Invention Grant
- Patent Title: Cannabinoid formulations
-
Application No.: US16760159Application Date: 2018-10-30
-
Publication No.: US11857530B2Publication Date: 2024-01-02
- Inventor: Len May , Eric Kaufman
- Applicant: Endocanna Health, Inc.
- Applicant Address: US CA Encino
- Assignee: ENDOCANNA HEALTH, INC.
- Current Assignee: ENDOCANNA HEALTH, INC.
- Current Assignee Address: US CA Burbank
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- International Application: PCT/US2018/058199 2018.10.30
- International Announcement: WO2019/089583A 2019.05.09
- Date entered country: 2020-04-29
- Main IPC: A61K31/352
- IPC: A61K31/352 ; A61K31/015 ; A61K31/05 ; G16H10/40 ; G16H10/60 ; G16H15/00 ; G16H50/70 ; G16H50/20 ; G16H70/40 ; G16H20/10 ; G16B20/20 ; G06F3/0484 ; A61K45/06
Abstract:
The disclosure is directed to formulations comprising cannabinoids. More particularly, the cannabinoid formulations can be designed to align with an individual's genotype based on a defined list of polymorphisms.
Public/Granted literature
- US20200253921A1 Cannabinoid Formulations Public/Granted day:2020-08-13
Information query
